Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (41-50 of 426) with videos related to

Pageof 43
Sort By:
Molecular and Cellular Biology|February 1, 1981
55,000-dalton, retrovirus-associated, cell membrane glycoprotein: purification and quantitative measurements of expression in viruses, cells, and tissuesD A Scheinberg, M Strand
Virology|October 30, 1980
Transformation-related proteins associated with Kirsten sarcoma virusD A Scheinberg, M Strand
Best Practice & Research. Clinical Haematology|September 16, 2008
Peptide vaccines for myeloid leukaemiasTao Dao, David A Scheinberg
Seminars in Radiation Oncology|March 2, 2011
Will nanotechnology influence targeted cancer therapy?Jan Grimm, David A Scheinberg
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Noninvasive evaluation of the bone marrowA Jakubowski, D A Scheinberg
Revista Paulista De Medicina|May 1, 1989
[Anti-HIV positivity at a reference laboratory]P Scheinberg, M A Scheinberg
Clinical and Experimental Rheumatology|November 1, 1990
Simultaneous evaluation of membrane bound and soluble interleukin 2 receptor expression in the blood and synovial fluid of patients with rheumatoid arthritisM Vaisberg, M A Scheinberg
Clinical and Experimental Immunology|July 1, 1978
New concepts in the pathogenesis of primary and secondary amyloid diseaseM A Scheinberg, E S Cathcart
Clinical and Experimental Immunology|May 1, 1976
Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritisM A Scheinberg, E S Cathcart
Current Radiopharmaceuticals|December 29, 2011
Actinium-225 in targeted alpha-particle therapeutic applicationsDavid A Scheinberg, Michael R McDevitt
Pageof 43

Showing results (41-50 of 426) with videos related to

Sort By:
Pageof 43
Molecular and Cellular Biology|February 1, 1981
55,000-dalton, retrovirus-associated, cell membrane glycoprotein: purification and quantitative measurements of expression in viruses, cells, and tissuesD A Scheinberg, M Strand
Virology|October 30, 1980
Transformation-related proteins associated with Kirsten sarcoma virusD A Scheinberg, M Strand
Best Practice & Research. Clinical Haematology|September 16, 2008
Peptide vaccines for myeloid leukaemiasTao Dao, David A Scheinberg
Seminars in Radiation Oncology|March 2, 2011
Will nanotechnology influence targeted cancer therapy?Jan Grimm, David A Scheinberg
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Noninvasive evaluation of the bone marrowA Jakubowski, D A Scheinberg
Revista Paulista De Medicina|May 1, 1989
[Anti-HIV positivity at a reference laboratory]P Scheinberg, M A Scheinberg
Clinical and Experimental Rheumatology|November 1, 1990
Simultaneous evaluation of membrane bound and soluble interleukin 2 receptor expression in the blood and synovial fluid of patients with rheumatoid arthritisM Vaisberg, M A Scheinberg
Clinical and Experimental Immunology|July 1, 1978
New concepts in the pathogenesis of primary and secondary amyloid diseaseM A Scheinberg, E S Cathcart
Clinical and Experimental Immunology|May 1, 1976
Antibody-dependent direct cytotoxicity of human lymphocytes. II. Studies on peripheral blood lymphocytes, synovial fluid cells and sera from patients with rheumatoid arthritisM A Scheinberg, E S Cathcart
Current Radiopharmaceuticals|December 29, 2011
Actinium-225 in targeted alpha-particle therapeutic applicationsDavid A Scheinberg, Michael R McDevitt
Pageof 43